WIPO
open access
CC BY 4.0
Regulatory pathways and guidelines for nanotechnology-enabled health products: a comparative review of EU and US frameworks
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- A decade of clinical trials in Italy (2016–2025): trends, regulatory transformation and biotechnological evolution.#340558
- Systemic path to global health 2050#344553
- Delayed and non-linear systemic effects of mixed alumina nanoparticle and hydrogen chloride inhalation revealed by metabolomics#179486
- Emerging Biotechnologies in Europe: Foresight for Policy#271042
- Towards a greener pharmaceuticals' regulatory highway#416978
Record · ID 163561
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive